Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørSekvenser genomet ditt↗
Traits
Traits linked to TP53
tumor protein p53
The Human Phenotype Ontology links 214 traits to TP53, by body system: features seen in people with one of the gene's rare conditions.
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørSekvenser genomet ditt↗
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørSekvenser genomet ditt↗
Abnormality of the nervous system
Abnormality of blood and blood-forming tissues
Abnormality of the digestive system
Abnormality of the genitourinary system
| Trait | Hvor ofte den forekommer |
|---|---|
| Abnormal fallopian tube morphology | Svært ofte (80–99 %) |
| Ovarian cancer | Svært ofte (80–99 %) |
| Abnormal absence of menstruation | Ofte (30–79 %) |
| Abnormality of reproductive system physiology | Ofte (30–79 %) |
| Testicular degeneration | Ofte (30–79 %) |
| Abnormal libido | Noen ganger (5–29 %) |
| Light or infrequent menstrual periods | Noen ganger (5–29 %) |
| Ovarian carcinoma | Noen ganger (5–29 %) |
| Previous menstrual periods stop | Noen ganger (5–29 %) |
| Prostate cancer | Noen ganger (5–29 %) |
| Kidney cancer | Sjelden (1–4%) |
| Testicular cancer | Sjelden (1–4%) |
| Cancer starting in small tubes in kidneys | Ikke registrert |
| Nephroblastoma | Ikke registrert |
| Prostate neoplasm | Ikke registrert |
| Transitional cell carcinoma of the bladder | Ikke registrert |
| Uterine leiomyosarcoma | Ikke registrert |
Abnormality of the endocrine system
| Trait | Hvor ofte den forekommer |
|---|---|
| Adrenocortical carcinoma | Alltid |
| Decreased activity of gonads | Alltid |
| Increased circulating cortisol level | Svært ofte (80–99 %) |
| Paradoxical increased cortisol secretion on dexamethasone suppression test | Svært ofte (80–99 %) |
| Pituitary corticotropic cell adenoma | Svært ofte (80–99 %) |
| Abnormal circulating dehydroepiandrosterone concentration | Ofte (30–79 %) |
| Adrenocorticotropic hormone deficiency | Ofte (30–79 %) |
| Elevated plasma aldosterone | Ofte (30–79 %) |
| Elevated serum 11-deoxycortisol | Ofte (30–79 %) |
| Enlarged adrenal glands | Ofte (30–79 %) |
| Increased circulating ACTH level | Ofte (30–79 %) |
| Increased circulating androgen concentration | Ofte (30–79 %) |
| Increased circulating androstenedione concentration | Ofte (30–79 %) |
| Increased serum estradiol | Ofte (30–79 %) |
| Thyroid carcinoma | Sjelden (1–4%) |
Abnormality of the integument
| Trait | Hvor ofte den forekommer |
|---|---|
| Choroid plexus papilloma | Alltid |
| Reticular hyperpigmentation | Alltid |
| Buffalo hump | Ofte (30–79 %) |
| Excessive hair growth | Ofte (30–79 %) |
| Excessive hairiness | Ofte (30–79 %) |
| Excessive sweating | Ofte (30–79 %) |
| Patchy darkened skin | Ofte (30–79 %) |
| Plethora | Ofte (30–79 %) |
| Poor wound healing | Ofte (30–79 %) |
| Stretch marks | Ofte (30–79 %) |
| Thin skin | Ofte (30–79 %) |
| Flushing | Noen ganger (5–29 %) |
| Open skin sore | Noen ganger (5–29 %) |
| Basal cell carcinoma | Ikke registrert |
Abnormality of the musculoskeletal system
| Trait | Hvor ofte den forekommer |
|---|---|
| Bone cell cancer | Alltid |
| Back pain | Svært ofte (80–99 %) |
| Breakdown of bone | Svært ofte (80–99 %) |
| Delayed bone maturation | Ofte (30–79 %) |
| Fatiguable weakness of proximal limb muscles | Ofte (30–79 %) |
| Muscle weakness | Ofte (30–79 %) |
| Osteoporosis | Ofte (30–79 %) |
| Wasting of muscles near the body | Ofte (30–79 %) |
| Compression fracture of a vertebral body | Noen ganger (5–29 %) |
| Rhabdomyosarcoma | Noen ganger (5–29 %) |
| Spasticity and rigidity of muscles | Noen ganger (5–29 %) |
| Death of bone due to decreased blood supply | Sjelden (1–4%) |
| Spontaneous fracture | Sjelden (1–4%) |
Laboratory abnormality
| Trait | Hvor ofte den forekommer |
|---|---|
| High urine cortisol level | Svært ofte (80–99 %) |
| Abnormal circulating lactate dehydrogenase concentration | Ofte (30–79 %) |
| Diabetes mellitus | Ofte (30–79 %) |
| Elevated alkaline phosphatase | Ofte (30–79 %) |
| Impaired glucose tolerance | Ofte (30–79 %) |
| Increased circulating lactate dehydrogenase concentration | Ofte (30–79 %) |
| Joint swelling | Ofte (30–79 %) |
| Laboratory abnormality | Ofte (30–79 %) |
| Low blood potassium levels | Ofte (30–79 %) |
| High liver enzymes | Noen ganger (5–29 %) |
| Pee issues | Noen ganger (5–29 %) |
| Fever | Sjelden (1–4%) |
| Increased level of L-fucose in urine | Ikke registrert |
Abnormality of the cardiovascular system
| Trait | Hvor ofte den forekommer |
|---|---|
| Abnormality of the cerebral blood vessels | Svært ofte (80–99 %) |
| Heart attack | Svært ofte (80–99 %) |
| Abnormality of the cardiovascular system | Ofte (30–79 %) |
| Capillary fragility | Ofte (30–79 %) |
| High blood pressure | Ofte (30–79 %) |
| Increased spleen size | Ofte (30–79 %) |
| Palpitations | Ofte (30–79 %) |
| Swollen lymph nodes | Ofte (30–79 %) |
| Enlarged liver and spleen | Noen ganger (5–29 %) |
| Livedo reticularis | Noen ganger (5–29 %) |
| Mini stroke | Noen ganger (5–29 %) |
| Stroke | Noen ganger (5–29 %) |
Abnormality of head or neck
| Trait | Hvor ofte den forekommer |
|---|---|
| Abnormally small head | Alltid |
| Dark color of gums | Ofte (30–79 %) |
| Moon face | Ofte (30–79 %) |
| Big sella turcica | Noen ganger (5–29 %) |
| Sparse scalp hair | Noen ganger (5–29 %) |
| Neoplasia of the nasopharynx | Ikke registrert |
Abnormality of the eye
| Trait | Hvor ofte den forekommer |
|---|---|
| Amaurosis fugax | Svært ofte (80–99 %) |
| Visual impairment | Noen ganger (5–29 %) |
| Optic nerve compression | Sjelden (1–4%) |
| Partial loss of field of vision | Sjelden (1–4%) |
| Papilledema | Ikke registrert |
| Retina tumor | Ikke registrert |
Growth abnormality
| Trait | Hvor ofte den forekommer |
|---|---|
| Growth delay | Alltid |
| Short stature | Alltid |
| Weight loss | Svært ofte (80–99 %) |
| Abdominal obesity | Ofte (30–79 %) |
| Increased body weight | Ofte (30–79 %) |
| Truncal obesity | Ofte (30–79 %) |
Abnormal tissue mass
| Trait | Hvor ofte den forekommer |
|---|---|
| Abnormal tissue mass | Svært ofte (80–99 %) |
| Cancer of skin pigment cells | Noen ganger (5–29 %) |
| Central primitive neuroectodermal tumor | Noen ganger (5–29 %) |
| Head and neck tumor | Sjelden (1–4%) |
| Soft tissue sarcoma | Ikke registrert |
Constitutional symptom
| Trait | Hvor ofte den forekommer |
|---|---|
| Chest pain | Svært ofte (80–99 %) |
| Chronic fatigue | Svært ofte (80–99 %) |
| Fatigue | Svært ofte (80–99 %) |
| Pain | Ofte (30–79 %) |
| Erythromelalgia | Noen ganger (5–29 %) |
Abnormality of limbs
| Trait | Hvor ofte den forekommer |
|---|---|
| Abnormality of the wide portion of the femoral bone | Svært ofte (80–99 %) |
| Abnormality of the wide portion of a long bone | Ofte (30–79 %) |
| Abnormality of the wide portion of shankbone | Ofte (30–79 %) |
| Fluid accumulation in lower limbs | Sjelden (1–4%) |
Abnormality of the respiratory system
| Trait | Hvor ofte den forekommer |
|---|---|
| Lung adenocarcinoma | Ofte (30–79 %) |
| Abnormality of the respiratory system | Noen ganger (5–29 %) |
| Lung cancer | Sjelden (1–4%) |
| Neoplasm of the larynx | Sjelden (1–4%) |
Abnormality of the immune system
| Trait | Hvor ofte den forekommer |
|---|---|
| Acne | Ofte (30–79 %) |
| Decreased immune function | Ofte (30–79 %) |
| Recurrent cutaneous fungal infections | Noen ganger (5–29 %) |
Abnormal cellular phenotype
| Trait | Hvor ofte den forekommer |
|---|---|
| Decreased circulating antibody level | Alltid |
| Short telomere length | Alltid |
Abnormality of prenatal development or birth
| Trait | Hvor ofte den forekommer |
|---|---|
| Choriocarcinoma | Sjelden (1–4%) |
Abnormality of the breast
| Trait | Hvor ofte den forekommer |
|---|---|
| Breast cancer | Ofte (30–79 %) |
Abnormality of the ear
| Trait | Hvor ofte den forekommer |
|---|---|
| Dizziness | Ofte (30–79 %) |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Slik er informasjonen samlet
- The Human Phenotype Ontology, release 2026-09-01: the traits linked to TP53 and how often each is seen. Find out more at hpo.jax.org.
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørSekvenser genomet ditt↗
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker